Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

4/28/2018 Database Update: Pharmaceutical Drug Import from EEU Countries to Russia (March 2018)

Between January and March 2018, Russia imported 2.7 bln RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 42.8% higher than that of the same period of 2017. In physical terms, the import amounted to 40.5 mln units, which is 22.7% lower than that of the same period of 2017.

4/25/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (March 2018)

Between January and March 2018, Russia produced 75.7 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is 0.5% higher than that of the same period of 2017. In physical terms, it is around 1.01 bln units, which is 10% lower than that of the same period of 2017.

4/24/2018 Database Update: Import of Veterinary Drugs, Feed, Feed Supplements and APIs to Russia (February 2018)

In February 2018, Russia imported 4.6 bln RUB worth of veterinary products, which is in monetary terms 8% higher than that of February 2017. The import of feed supplements amounted to 2.52 bln RUB, with a 12.5% increase. The import of veterinary drugs follows with 1.95 bln RUB and a 3.6% increase, while the import of veterinary APIs amounted to 0.14 bln RUB and a 5.1 decrease.

4/19/2018 Database Update: API Import to Russia (February 2018)

Between January and February 2018, Russia imported 14.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 45% higher than that of the same period of 2017. In physical terms, Russia imported 1,760,000 tons of APIs, which is 9% higher than that of the same period of 2017.

4/18/2018 Database Update: Pharmaceutical Drug Import to Russia (February 2018)

Between January and February 2018, Russia imported 70.4 bln RUB worth of ready-made pharmaceutical drugs and 14.1 bln RUB worth of in-bulk drugs (free circulation prices), which is in monetary terms 10.2% higher and 3.1% lower than that of the same period of 2017, respectively. In total, the dynamics for the period are 7.7%.

All news [87]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.